AMPLIMMUNE
Amplimmune is a product driven company that is developing immune-based biologics to treat patients in the areas of cancer, autoimmunity, transplantation and infectious diseases. Amplimmune's scientific founders from Johns Hopkins University have identified several key immunological ligands and receptors. These immunological checkpoint and co-stimulatory molecules are the basis for developing a new class of biological treatments which modulate critical mechanisms in the body's immune system with the aim of bettering the lives of patients suffering from aberrant immunological conditions.
AMPLIMMUNE
Industry:
Biotechnology Health Care Medical
Founded:
2006-01-01
Address:
Rockville, Maryland, United States
Country:
United States
Website Url:
http://www.amplimmune.com
Total Employee:
1001+
Status:
Active
Contact:
3013099800
Email Addresses:
[email protected]
Total Funding:
20 M USD
Technology used in webpage:
SPF Amazon IPv6 Microsoft Azure DNS Amazon Ohio Region Mimecast Level 3 Communications
Similar Organizations
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
Henry Ford Health System
Henry Ford Health System (HFHS) is one of the nation’s leading comprehensive, integrated health systems.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
InterWest Partners
InterWest Partners investment in Series A - Amplimmune
Wellcome Trust
Wellcome Trust investment in Series A - Amplimmune
Official Site Inspections
http://www.amplimmune.com
- Host name: ec2-100-28-104-175.compute-1.amazonaws.com
- IP address: 100.28.104.175
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Amplimmune"
Amplimmune Company Profile 2024: Valuation, …
Amplimmune was founded in 2006. Where is Amplimmune headquartered? Amplimmune is headquartered in Gaithersburg, MD. What is the size of Amplimmune? Amplimmune has 22 total employees. What industry is …See details»
Amplimmune - Ownership and Business Overview - Mergr
Aug 26, 2013 Amplimmune, Inc. is a biologics company focused on developing novel therapeutics in cancer immunology. Company Summary. SECTOR. Life Science. Established. …See details»
Amplimmune - VentureRadar
Amplimmune develops immune-based biologics to treat patients in the areas of cancer, autoimmunity, transplantation and infectious diseases. Its founders have identified key …See details»
Amplimmune - Funding, Financials, Valuation & Investors
Amplimmune is a product-driven company offering immune-based biologics to treat patients with cancer, autoimmunity, and infectious diseases. ... How much funding has this organization …See details»
Amplimmune - Overview, News & Similar companies
With its strong product-based focus, Amplimmune has rapidly developed three biologic product candidates: AMP-224 is in Phase 1b trials in cancer; AMP-110 for autoimmune diseases in …See details»
Amplimmune Inc - Company Profile and News - Bloomberg Markets
Company profile page for Amplimmune Inc including stock price, company news, executives, board members, and contact informationSee details»
MedImmune Completes Acquisition of Amplimmune - AstraZeneca
Oct 7, 2013 Other Amplimmune assets include multiple preclinical molecules targeting the B7 pathways. MedImmune, with its clinical stage programmes – tremelimumab, mOX40 mAb and …See details»
Amplimmune Company Profile | Management and Employees List
Find contact information for Amplimmune. Learn about their Manufacturing market share, competitors, and Amplimmune's email format. Company Overview. Team Members. Email …See details»
Amplimmune - Company Profile - Tracxn
Amplimmune - Develops immune-based biologics for treatment of cancer, autoimmunity, transplantation, and infectious diseases. Acquired by MedImmune. Raised a total funding of …See details»
Amplimmune, Inc.: Contact Details and Business Profile
What is the NAICS code for Amplimmune, Inc.? The NAICS codes for Amplimmune, Inc. are [325, 32, 325413, 325414, 32541, 3254]. What is the SIC code for Amplimmune, Inc.? The SIC …See details»
Amplimmune - Contacts, Employees, Board Members, Advisors
Organization. Amplimmune . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... Contacts 92. About. Amplimmune has 2 current …See details»
MedImmune completes $500m acquisition of Amplimmune
Oct 8, 2013 Amplimmune is a US-based biologics company that focuses on developing novel therapeutics in cancer immunology. The acquisition boosts MedImmune's oncology pipeline by …See details»
Amplimmune Gets $23M Up Front from GSK to Develop PD-1 …
Aug 4, 2010 Amplimmune’s AMP-224 is an Fc-fusion protein designed to block interaction between PD-1 and B7-H1 to overcome immune suppression and allow the immune system to …See details»
AstraZeneca forges $500M cancer immunotherapy buyout for …
Aug 26, 2013 AstraZeneca is rolling the dice on a $500 million deal--including $225 million upfront--to buy the early-stage cancer immunology specialist Amplimmune for its U.S. …See details»
Amplimmune - Tech Stack, Apps, Patents & Trademarks
Amplimmune is a product-driven company offering immune-based biologics to treat patients with cancer, autoimmunity, and infectious diseases. Search Crunchbase Start Free TrialSee details»
Novavive Inc.
OMRI is a nonprofit organization that provides an independent review of products, such as fertilizers, pest controls, livestock health care products, and numerous other inputs that are …See details»
Novavive Inc.
Amplimune, mycobacterium cell wall fraction (MCWF) immunostimulant, is approved by the CFIA for the treatment of bovine infectious disease. Amplimune is recommended as a one-time …See details»
Amplimune an alternative for herd health as FDA further restricts ...
May 31, 2023 As the US Food & Drug Administration (FDA) heads toward full implementation of its plan for supporting veterinary antimicrobial stewardship, NovaVive Inc. offers an antibiotic …See details»
Amplimune for Animal Use (Canada) - Drugs.com
Company: NovaVive MYCOBACTERIUM CELL WALL IMMUNOSTIMULANT. FOR VETERINARY USE ONLY. Description and Action: The Mycobacteriaceae have been known …See details»